The American Journal of Managed Care

FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on ...

The FDA announced Friday that it intends to restrict the active pharmaceutical ingredients of glucagon-like peptide-1 (GLP-1) ...